Workiva (WK) 10-Q 2 May 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	Apr. 29, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-36773
Entity Registrant Name	WORKIVA INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-2509828
Entity Address, Address Line One	2900 University Blvd
Entity Address, City or Town	Ames
Entity Address, State or Province	IA
Entity Address, Postal Zip Code	50010
City Area Code	888
Local Phone Number	275-3125
Title of 12(b) Security	Class A common stock, par value $.001
Trading Symbol	WK
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001445305
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		50,979,294
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,845,583

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 296,066	$ 256,100
Marketable securities	542,281	557,622
Accounts receivable, net of allowance for doubtful accounts of $1,034 and $1,163 at March 31, 2024 and December 31, 2023, respectively	87,898	125,193
Deferred costs	37,822	39,023
Other receivables	7,162	7,367
Prepaid expenses and other	25,771	23,631
Total current assets	997,000	1,008,936
Property and equipment, net	23,295	24,282
Operating lease right-of-use assets	11,254	12,642
Deferred costs, non-current	32,848	33,346
Goodwill	110,317	112,097
Intangible assets, net	21,154	22,892
Other assets	6,036	4,665
Total assets	1,201,904	1,218,860
Current liabilities
Accounts payable	9,911	5,204
Accrued expenses and other current liabilities	89,437	97,921
Deferred revenue	367,060	380,843
Finance lease obligations	540	532
Total current liabilities	466,948	484,500
Convertible senior notes, non-current	763,063	762,455
Deferred revenue, non-current	31,085	36,177
Other long-term liabilities	212	178
Operating lease liabilities, non-current	9,839	10,890
Finance lease obligations, non-current	13,913	14,050
Total liabilities	1,285,060	1,308,250
Stockholders’ deficit
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding	0	0
Additional paid-in-capital	584,752	562,942
Accumulated deficit	(664,328)	(652,641)
Accumulated other comprehensive (loss) income	(3,635)	255
Total stockholders’ deficit	(83,156)	(89,390)
Total liabilities and stockholders’ deficit	1,201,904	1,218,860
Class A Common Stock
Stockholders’ deficit
Common stock	51	50
Class B Common Stock
Stockholders’ deficit
Common stock	$ 4	$ 4

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Allowance for doubtful accounts	$ 1,034	$ 1,163
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	50,939,332	50,333,435
Common stock, shares outstanding (in shares)	50,939,332	50,333,435
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	3,845,583	3,845,583
Common stock, shares outstanding (in shares)	3,845,583	3,845,583

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 175,667	$ 150,189
Cost of revenue
Total cost of revenue	41,523	38,518
Gross profit	134,144	111,671
Operating expenses
Research and development	45,495	45,791
Sales and marketing	82,633	70,710
General and administrative	24,299	42,011
Total operating expenses	152,427	158,512
Loss from operations	(18,283)	(46,841)
Interest income	10,455	3,717
Interest expense	(3,232)	(1,501)
Other income (expense), net	86	(940)
Loss before provision for income taxes	(10,974)	(45,565)
Provision for income taxes	713	585
Net loss	$ (11,687)	$ (46,150)
Net loss per common share:
Basic (in dollars per share)	$ (0.21)	$ (0.86)
Diluted (in dollars per share)	$ (0.21)	$ (0.86)
Weighted-average common shares outstanding - basic (in shares)	54,915,852	53,690,242
Weighted-average common shares outstanding - diluted (in shares)	54,915,852	53,690,242
Subscription and support
Revenue
Total revenue	$ 154,979	$ 129,664
Cost of revenue
Total cost of revenue	27,927	24,133
Professional services
Revenue
Total revenue	20,688	20,525
Cost of revenue
Total cost of revenue	$ 13,596	$ 14,385

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (11,687)	$ (46,150)
Other comprehensive (loss) income
Foreign currency translation adjustment	(2,483)	1,701
Unrealized (loss) gain on available-for-sale securities	(1,407)	1,579
Other comprehensive (loss) income	(3,890)	3,280
Comprehensive loss	$ (15,577)	$ (42,870)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock (Class A and B)	Additional Paid-in-Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning of the period (in shares) at Dec. 31, 2022		52,652,000
Beginning of the period at Dec. 31, 2022	$ 5,983	$ 53	$ 537,732	$ (6,686)	$ (525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	38,042		38,042
Issuance of common stock upon exercise of stock options (in shares)		102,000
Issuance of common stock upon exercise of stock options	1,457		1,457
Issuance of common stock under employee stock purchase plan (in shares)		107,000
Issuance of common stock under employee stock purchase plan	5,546		5,546
Issuance of restricted stock units (in shares)		449,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)		(78,000)
Tax withholding related to net share settlements of stock-based compensation awards	(7,228)		(7,228)
Net loss	(46,150)				(46,150)
Other comprehensive (loss) income	3,280			3,280
End of period (in shares) at Mar. 31, 2023		53,232,000
End of period at Mar. 31, 2023	930	$ 53	575,549	(3,406)	(571,266)
Beginning of the period (in shares) at Dec. 31, 2023		54,179,000
Beginning of the period at Dec. 31, 2023	(89,390)	$ 54	562,942	255	(652,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 23,007		23,007
Issuance of common stock upon exercise of stock options (in shares)	18,943	19,000
Issuance of common stock upon exercise of stock options	$ 302	$ 1	301
Issuance of common stock under employee stock purchase plan (in shares)		88,000
Issuance of common stock under employee stock purchase plan	7,113		7,113
Issuance of restricted stock units (in shares)		590,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)		(91,000)
Tax withholding related to net share settlements of stock-based compensation awards	(8,611)		(8,611)
Net loss	(11,687)				(11,687)
Other comprehensive (loss) income	(3,890)			(3,890)
End of period (in shares) at Mar. 31, 2024		54,785,000
End of period at Mar. 31, 2024	$ (83,156)	$ 55	$ 584,752	$ (3,635)	$ (664,328)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (11,687)	$ (46,150)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,522	2,800
Stock-based compensation expense	23,007	38,042
(Recovery of) provision for doubtful accounts	(123)	106
Realized loss on sale of available-for-sale securities, net	0	561
Amortization of premiums and discounts on marketable securities, net	(3,749)	(1,028)
Amortization of issuance costs and debt discount	608	325
Deferred income tax	(295)	(10)
Changes in assets and liabilities:
Accounts receivable	36,947	29,363
Deferred costs	1,405	1,770
Operating lease right-of-use asset	1,426	1,295
Other receivables	194	95
Prepaid expenses and other	(2,273)	(5,732)
Other assets	(1,090)	(74)
Accounts payable	4,726	207
Deferred revenue	(17,526)	(9,955)
Operating lease liability	(987)	(1,172)
Accrued expenses and other liabilities	(8,261)	(4,880)
Net cash provided by operating activities	24,844	5,563
Cash flows from investing activities
Purchase of property and equipment	(203)	(198)
Purchase of marketable securities	(116,567)	(125,815)
Sale of marketable securities	4,609	43,713
Maturities of marketable securities	129,640	31,905
Purchase of intangible assets	(31)	(79)
Net cash provided by (used in) investing activities	17,448	(50,474)
Cash flows from financing activities
Proceeds from option exercises	302	1,457
Taxes paid related to net share settlements of stock-based compensation awards	(8,611)	(7,228)
Proceeds from shares issued in connection with employee stock purchase plan	7,113	5,546
Principal payments on finance lease obligations	(129)	(124)
Net cash used in financing activities	(1,325)	(349)
Effect of foreign exchange rates on cash	(1,107)	548
Net increase (decrease) in cash, cash equivalents and restricted cash	39,860	(44,712)
Cash, cash equivalents and restricted cash at beginning of period	256,721	240,197
Cash, cash equivalents and restricted cash at end of period	296,581	195,485
Supplemental cash flow disclosure
Cash paid for interest	4,906	2,146
Cash paid for income taxes, net of refunds	952	323
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents at end of period	296,066	195,485
Restricted cash included within prepaid expenses and other at end of period	515	0
Total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows	$ 296,581	$ 195,485

Organization and Significant Ac

Organization and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	Organization and Significant Accounting Policies Organization Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) is on a mission to power transparent reporting for a better world. We believe that consumers, employees, shareholders, and other stakeholders today expect more from business – more action, transparency, and disclosure of financial and non-financial information. We build solutions to meet that demand and streamline processes, connect data and teams, and ensure consistency – all within the Workiva platform, the world’s leading cloud platform for assured integrated reporting. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada. Basis of Presentation and Principles of Consolidation The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2023 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2024 are not necessarily indicative of the results expected for the full year ending December 31, 2024. Seasonality affects our revenue, expenses and cash flows from operations. Revenue from professional services is generally higher in the first quarter as many of our customers file their 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. Sales and marketing expenses have historically been higher in the third quarter due to our annual user conference in September. In addition, the timing of cash bonus payments to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC on February 20, 2024. The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. Recently Adopted Accounting Pronouncements None. New Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands disclosures about a public entity’s reportable segments and requires more enhanced information about a reportable segment’s expenses, interim segment profit or loss, and how a public entity’s chief operating decision maker uses reported segment profit or loss information in assessing segment performance and allocating resources. The standard is effective for annual periods beginning after December 15, 2023, with early adoption permitted. We are assessing the effect of adopting this standard on our consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are assessing the effect of adopting this standard on our consolidated financial statements and related disclosures.

Supplemental Consolidated Balan

Supplemental Consolidated Balance Sheet Information	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Supplemental Consolidated Balance Sheet Information	Supplemental Consolidated Balance Sheet Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2024 As of December 31, 2023 Accrued vacation $ 17,759 $ 15,356 Accrued commissions 7,843 11,969 Accrued bonuses 8,256 6,825 Accrued payroll 7,660 7,206 Estimated health insurance claims 2,463 3,462 Accrued interest 1,197 3,510 ESPP employee contributions 4,319 7,540 Customer deposits 22,307 24,763 Operating lease liabilities 4,489 5,256 Accrued other liabilities 13,144 12,034 $ 89,437 $ 97,921

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities At March 31, 2024, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 120,399 $ — $ — $ 120,399 Commercial paper 21,119 — — 21,119 U.S. treasury debt securities 263,751 84 (283) 263,552 U.S. government agency debt securities 99,374 45 (103) 99,316 Corporate debt securities 178,987 145 (298) 178,834 Foreign government debt securities 1,000 — (2) 998 $ 684,630 $ 274 $ (686) $ 684,218 Included in cash and cash equivalents $ 141,937 $ — $ — $ 141,937 Included in marketable securities $ 542,693 $ 274 $ (686) $ 542,281 At December 31, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 108,826 $ — $ — $ 108,826 Commercial paper 56,115 — — 56,115 U.S. treasury debt securities 224,136 531 (80) 224,587 U.S. government agency debt securities 110,036 256 (15) 110,277 Corporate debt securities 165,341 497 (187) 165,651 Foreign government debt securities 999 — (7) 992 $ 665,453 $ 1,284 $ (289) $ 666,448 Included in cash and cash equivalents $ 108,826 $ — $ — $ 108,826 Included in marketable securities $ 556,627 $ 1,284 $ (289) $ 557,622 The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2024 Due within one year $ 359,459 Due in one to two years 182,822 $ 542,281 The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2024, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2024 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 191,040 $ (275) $ 2,083 $ (8) U.S. government agency debt securities 68,527 (103) — — Corporate debt securities 113,420 (270) 7,983 (28) Foreign government debt securities — — 998 (2) Total $ 372,987 $ (648) $ 11,064 $ (38) We do not believe the unrealized losses represent credit losses based on our evaluation of available evidence as of March 31, 2024, which includes an assessment of whether it is more likely than not we will be required to sell the investment before recovery of the investment's amortized cost basis.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We determine the fair values of our financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 - Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 - Inputs are unobservable inputs based on our assumptions. Financial Assets Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. As of March 31, 2024, all of our marketable securities were valued using quoted prices for comparable instruments in active markets and are classified as Level 2. Based on our valuation of our money market funds and marketable securities, we concluded that they are classified in either Level 1 or Level 2, and we have no financial assets measured using Level 3 inputs on a recurring basis. The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2024 Fair Value Measurements as of December 31, 2023 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 120,399 $ 120,399 $ — $ 108,826 $ 108,826 $ — Commercial paper 21,119 — 21,119 56,115 — 56,115 U.S. treasury debt securities 263,552 — 263,552 224,587 — 224,587 U.S. government agency debt securities 99,316 — 99,316 110,277 — 110,277 Corporate debt securities 178,834 — 178,834 165,651 — 165,651 Foreign government debt securities 998 — 998 992 — 992 $ 684,218 $ 120,399 $ 563,819 $ 666,448 $ 108,826 $ 557,622 Included in cash and cash equivalents $ 141,937 $ 108,826 Included in marketable securities $ 542,281 $ 557,622 Convertible Senior Notes As of March 31, 2024, the fair value of our convertible senior notes due in 2026 and 2028 was $86.2 million and $651.9 million, respectively. The fair value was determined based on the quoted price of the convertible senior notes in an over-the-counter market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. See Note 5 to the condensed consolidated financial statements for more information.

Convertible Senior Notes

Convertible Senior Notes	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands): Month Issued Maturity Date Free Convertibility Date Redemption Date Original Principal (including overallotment) Initial Conversion Rate per $1,000 Principal Initial Conversion Price 2026 Notes August 2019 August 15, 2026 May 15, 2026 August 21, 2023 $ 345,000 12.4756 $ 80.16 2028 Notes August 2023 August 15, 2028 May 15, 2028 August 21, 2026 $ 702,000 7.4690 $ 133.89 In August 2019, we issued $345.0 million aggregate principal amount of 1.125% convertible senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the exercise in full by the initial purchasers of their option to purchase an additional $45.0 million principal amount (the "2026 Notes”). The 2026 Notes bear interest at a fixed rate of 1.125% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2020. Proceeds from the issuance of the 2026 Notes totaled $335.9 million, net of initial purchaser discounts and issuance costs. In August 2023, we issued $702.0 million aggregate principal amount of 1.250% convertible senior notes due 2028 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the partial exercise of 77.0 million principal amount by the initial purchasers of their option to purchase up to an additional $100 million principal amount (the "2028 Notes”). The 2028 Notes bear interest at a fixed rate of 1.250% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2024. Proceeds from the issuance of the 2028 Notes totaled $691.1 million, net of initial purchaser discounts and issuance costs. The 2026 Notes and the 2028 Notes are together referred to as the "Notes". The Notes were issued pursuant to an indenture and are senior, unsecured obligations of the Company. The 2028 Notes will rank equally with all of the Company’s existing and future senior unsecured indebtedness, including the Company’s outstanding 2026 Notes. Holders of the Notes may convert all or a portion of their Notes prior to the close of business on their respective Free Convertibility dates, in multiples of $1,000 principal amount, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter in which the respective Notes were issued (and only during such calendar quarter), if the last reported sale price of our Class A common stock, par value $0.001 per share (which we refer to in this offering memorandum as our “Class A common stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • during the five consecutive business day period immediately following any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined below) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Class A common stock and the conversion rate on each such trading day; • if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • upon the occurrence of certain specified corporate events as set forth in the relevant indenture. On or after the relevant Free Convertibility Date, holders of the Notes may convert their Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Notes. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of our Class A common stock, at our election, in the manner and subject to the terms and conditions provided in the indenture. The Company may redeem for cash all or any portion of the Notes, at its option, on or after the respective Redemption Date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the respective Redemption Date. During the first quarter of 2024 none of the conversion conditions were met and therefore the Notes are not convertible at the option of the holders. As a result, the Notes were classified as non-current liabilities on the condensed consolidated balance sheet as of March 31, 2024. Interest expense representing the amortization of issuance costs as well as contractual interest expense is amortized to interest expense at an effective interest rate of 1.5% and 1.6% over the term of the 2026 Notes and 2028 Notes, respectively. As of March 31, 2024, the remaining life of the 2026 Notes and 2028 Notes were approximately 2.3 years and 4.4 years, respectively. The net carrying amount of the Notes was as follows (in thousands): March 31, 2024 December 31, 2023 2026 Notes 2028 Notes 2026 Notes 2028 Notes Principal $ 71,242 $ 702,000 $ 71,242 $ 702,000 Unamortized issuance costs (643) (9,536) (711) (10,076) Net carrying amount $ 70,599 $ 692,464 $ 70,531 $ 691,924 Interest expense related to the Notes was as follows (in thousands): Three months ended March 31, 2024 2023 Contractual interest expense $ 2,394 $ 970 Amortization of issuance costs 608 325 Total interest expense $ 3,002 $ 1,295

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation We grant stock-based incentive awards to attract, motivate and retain qualified employees, non-employee directors and consultants, and to align their financial interests with those of our stockholders. We utilize stock-based compensation in the form of restricted stock units, performance restricted stock units, options to purchase Class A common stock and Employee Stock Purchase Plan ("ESPP") purchase rights. Prior to our corporate conversion in December 2014, awards were provided under the 2009 Unit Incentive Plan (“the 2009 Plan”). The 2009 Plan was amended to provide that no further awards will be issued thereunder, and our board of directors and stockholders adopted and approved our 2014 Equity Incentive Plan (“the 2014 Plan” and, together with the 2009 Plan, “the Plans”). Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2024 2023 Cost of revenue Subscription and support $ 1,601 $ 1,072 Professional services 727 633 Operating expenses Research and development 4,641 4,697 Sales and marketing 8,038 6,958 General and administrative 8,000 24,682 Total $ 23,007 $ 38,042 Stock Options The following table summarizes the option activity under the Plans for the three months ended March 31, 2024: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2023 1,211,619 $ 14.46 2.3 Granted — — Forfeited — — Expired — — Exercised (18,943) 15.93 Outstanding at March 31, 2024 1,192,676 $ 14.43 2.1 Exercisable at March 31, 2024 1,192,676 $ 14.43 2.1 Restricted Stock Units and Performance Restricted Stock Units The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the three months ended March 31, 2024: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2023 2,198,411 $ 97.17 Granted 947,282 94.78 Forfeited (39,340) 101.42 Vested (1) (575,242) 98.25 Unvested at March 31, 2024 2,531,111 $ 96.02 (1) During the three months ended March 31, 2024, in accordance with our Nonqualified Deferred Compensation Plan, no recipients elected to defer settlement of their vested restricted stock units and 14,840 shares were released from deferral. Employee Stock Purchase Plan During the three months ended March 31, 2024, 88,047 shares of common stock were purchased under the ESPP at a weighted-average price of $80.79 per share, resulting in cash proceeds of $7.1 million.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2024 2023 Subscription and support $ 154,979 $ 129,664 XBRL professional services 17,593 16,733 Other services 3,095 3,792 Total revenues $ 175,667 $ 150,189 Deferred Revenue We recognized $142.3 million and $118.4 million of revenue during the three months ended March 31, 2024 and 2023, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. Transaction Price Allocated to the Remaining Performance Obligations

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill The following table presents the components of net intangible assets (in thousands): As of March 31, 2024 As of December 31, 2023 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4.5 $ 15,765 $ (8,294) $ 7,471 $ 15,949 $ (7,471) $ 8,478 Acquired customer-related 10.0 15,081 (3,084) 11,997 15,427 (2,769) 12,658 Acquired trade names 2.9 2,156 (1,750) 406 2,172 (1,721) 451 Patents 10.0 3,182 (1,902) 1,280 3,150 (1,845) 1,305 Total 7.2 $ 36,184 $ (15,030) $ 21,154 $ 36,698 $ (13,806) $ 22,892 Amortization expense related to intangible assets was $1.4 million and $1.5 million for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2024 $ 4,074 2025 4,699 2026 3,380 2027 2,085 2028 1,648 Thereafter 5,268 Total expected amortization expense $ 21,154 The changes in the carrying amount of goodwill were as follows (in thousands): December 31, 2023 $ 112,097 Foreign currency translation adjustments (1,780) March 31, 2024 $ 110,317

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Net loss per share is allocated based on the contractual participation rights of the Class A and Class B common shares as if the loss for the year has been distributed. As the liquidation and dividend rights are identical, the net loss is allocated on a proportionate basis. A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2024 March 31, 2023 Class A Class B Class A Class B Numerator Net loss $ (10,869) $ (818) $ (42,819) $ (3,331) Denominator Weighted-average common shares outstanding - basic and diluted 51,070,269 3,845,583 49,815,159 3,875,083 Basic and diluted net loss per share $ (0.21) $ (0.21) $ (0.86) $ (0.86) The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2024 March 31, 2023 Shares subject to outstanding common stock options 1,192,676 1,406,771 Shares subject to unvested restricted stock units and performance restricted stock units 2,531,111 2,320,481 Shares issuable pursuant to the ESPP 98,587 99,352 Shares underlying our convertible senior notes 6,132,025 4,304,082

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (11,687)	$ (46,150)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024 shares
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Michael Hawkins [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On February 1, 2024, the pre-arranged stock trading plan pursuant to rule 10b5-1, adopted by Michael Hawkins, Executive Vice President of Sales, on September 11, 2023, automatically terminated pursuant to its terms. The expired plan provided for the potential sale of up to 20,152 shares of the Company's Class A common stock through February 9, 2024.
Name	Michael Hawkins
Title	Executive Vice President of Sales
Adoption Date	September 11, 2023
Rule 10b5-1 Arrangement Terminated	true
Termination Date	February 1, 2024
Aggregate Available	20,152

Organization and Significant _2

Organization and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2023 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2024 are not necessarily indicative of the results expected for the full year ending December 31, 2024.
Principles of Consolidation	All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted	None. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands disclosures about a public entity’s reportable segments and requires more enhanced information about a reportable segment’s expenses, interim segment profit or loss, and how a public entity’s chief operating decision maker uses reported segment profit or loss information in assessing segment performance and allocating resources. The standard is effective for annual periods beginning after December 15, 2023, with early adoption permitted. We are assessing the effect of adopting this standard on our consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. We are assessing the effect of adopting this standard on our consolidated financial statements and related disclosures.
Fair Value of Financial Instruments	Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service.

Supplemental Consolidated Bal_2

Supplemental Consolidated Balance Sheet Information (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2024 As of December 31, 2023 Accrued vacation $ 17,759 $ 15,356 Accrued commissions 7,843 11,969 Accrued bonuses 8,256 6,825 Accrued payroll 7,660 7,206 Estimated health insurance claims 2,463 3,462 Accrued interest 1,197 3,510 ESPP employee contributions 4,319 7,540 Customer deposits 22,307 24,763 Operating lease liabilities 4,489 5,256 Accrued other liabilities 13,144 12,034 $ 89,437 $ 97,921

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	At March 31, 2024, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 120,399 $ — $ — $ 120,399 Commercial paper 21,119 — — 21,119 U.S. treasury debt securities 263,751 84 (283) 263,552 U.S. government agency debt securities 99,374 45 (103) 99,316 Corporate debt securities 178,987 145 (298) 178,834 Foreign government debt securities 1,000 — (2) 998 $ 684,630 $ 274 $ (686) $ 684,218 Included in cash and cash equivalents $ 141,937 $ — $ — $ 141,937 Included in marketable securities $ 542,693 $ 274 $ (686) $ 542,281 At December 31, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 108,826 $ — $ — $ 108,826 Commercial paper 56,115 — — 56,115 U.S. treasury debt securities 224,136 531 (80) 224,587 U.S. government agency debt securities 110,036 256 (15) 110,277 Corporate debt securities 165,341 497 (187) 165,651 Foreign government debt securities 999 — (7) 992 $ 665,453 $ 1,284 $ (289) $ 666,448 Included in cash and cash equivalents $ 108,826 $ — $ — $ 108,826 Included in marketable securities $ 556,627 $ 1,284 $ (289) $ 557,622
Schedule of Cash and Cash Equivalents	At March 31, 2024, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 120,399 $ — $ — $ 120,399 Commercial paper 21,119 — — 21,119 U.S. treasury debt securities 263,751 84 (283) 263,552 U.S. government agency debt securities 99,374 45 (103) 99,316 Corporate debt securities 178,987 145 (298) 178,834 Foreign government debt securities 1,000 — (2) 998 $ 684,630 $ 274 $ (686) $ 684,218 Included in cash and cash equivalents $ 141,937 $ — $ — $ 141,937 Included in marketable securities $ 542,693 $ 274 $ (686) $ 542,281 At December 31, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 108,826 $ — $ — $ 108,826 Commercial paper 56,115 — — 56,115 U.S. treasury debt securities 224,136 531 (80) 224,587 U.S. government agency debt securities 110,036 256 (15) 110,277 Corporate debt securities 165,341 497 (187) 165,651 Foreign government debt securities 999 — (7) 992 $ 665,453 $ 1,284 $ (289) $ 666,448 Included in cash and cash equivalents $ 108,826 $ — $ — $ 108,826 Included in marketable securities $ 556,627 $ 1,284 $ (289) $ 557,622
Schedule of Investments Classified by Contractual Maturity Date	The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2024 Due within one year $ 359,459 Due in one to two years 182,822 $ 542,281
Schedule of Available-for-sale Securities, Continuous Unrealized Loss Position	The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2024, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2024 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 191,040 $ (275) $ 2,083 $ (8) U.S. government agency debt securities 68,527 (103) — — Corporate debt securities 113,420 (270) 7,983 (28) Foreign government debt securities — — 998 (2) Total $ 372,987 $ (648) $ 11,064 $ (38)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets Measured on Recurring Basis	The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2024 Fair Value Measurements as of December 31, 2023 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 120,399 $ 120,399 $ — $ 108,826 $ 108,826 $ — Commercial paper 21,119 — 21,119 56,115 — 56,115 U.S. treasury debt securities 263,552 — 263,552 224,587 — 224,587 U.S. government agency debt securities 99,316 — 99,316 110,277 — 110,277 Corporate debt securities 178,834 — 178,834 165,651 — 165,651 Foreign government debt securities 998 — 998 992 — 992 $ 684,218 $ 120,399 $ 563,819 $ 666,448 $ 108,826 $ 557,622 Included in cash and cash equivalents $ 141,937 $ 108,826 Included in marketable securities $ 542,281 $ 557,622

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Debt	The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands): Month Issued Maturity Date Free Convertibility Date Redemption Date Original Principal (including overallotment) Initial Conversion Rate per $1,000 Principal Initial Conversion Price 2026 Notes August 2019 August 15, 2026 May 15, 2026 August 21, 2023 $ 345,000 12.4756 $ 80.16 2028 Notes August 2023 August 15, 2028 May 15, 2028 August 21, 2026 $ 702,000 7.4690 $ 133.89 The net carrying amount of the Notes was as follows (in thousands): March 31, 2024 December 31, 2023 2026 Notes 2028 Notes 2026 Notes 2028 Notes Principal $ 71,242 $ 702,000 $ 71,242 $ 702,000 Unamortized issuance costs (643) (9,536) (711) (10,076) Net carrying amount $ 70,599 $ 692,464 $ 70,531 $ 691,924 Interest expense related to the Notes was as follows (in thousands): Three months ended March 31, 2024 2023 Contractual interest expense $ 2,394 $ 970 Amortization of issuance costs 608 325 Total interest expense $ 3,002 $ 1,295

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2024 2023 Cost of revenue Subscription and support $ 1,601 $ 1,072 Professional services 727 633 Operating expenses Research and development 4,641 4,697 Sales and marketing 8,038 6,958 General and administrative 8,000 24,682 Total $ 23,007 $ 38,042
Schedule of Stock-Option Activity	The following table summarizes the option activity under the Plans for the three months ended March 31, 2024: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2023 1,211,619 $ 14.46 2.3 Granted — — Forfeited — — Expired — — Exercised (18,943) 15.93 Outstanding at March 31, 2024 1,192,676 $ 14.43 2.1 Exercisable at March 31, 2024 1,192,676 $ 14.43 2.1
Schedule of Restricted Stock Units and Performance Restricted Stock Units Activity	The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the three months ended March 31, 2024: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2023 2,198,411 $ 97.17 Granted 947,282 94.78 Forfeited (39,340) 101.42 Vested (1) (575,242) 98.25 Unvested at March 31, 2024 2,531,111 $ 96.02 (1) During the three months ended March 31, 2024, in accordance with our Nonqualified Deferred Compensation Plan, no recipients elected to defer settlement of their vested restricted stock units and 14,840 shares were released from deferral.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2024 2023 Subscription and support $ 154,979 $ 129,664 XBRL professional services 17,593 16,733 Other services 3,095 3,792 Total revenues $ 175,667 $ 150,189

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of March 31, 2024 As of December 31, 2023 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4.5 $ 15,765 $ (8,294) $ 7,471 $ 15,949 $ (7,471) $ 8,478 Acquired customer-related 10.0 15,081 (3,084) 11,997 15,427 (2,769) 12,658 Acquired trade names 2.9 2,156 (1,750) 406 2,172 (1,721) 451 Patents 10.0 3,182 (1,902) 1,280 3,150 (1,845) 1,305 Total 7.2 $ 36,184 $ (15,030) $ 21,154 $ 36,698 $ (13,806) $ 22,892
Schedule of Expected Amortization Expense of Intangible Assets	As of March 31, 2024, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2024 $ 4,074 2025 4,699 2026 3,380 2027 2,085 2028 1,648 Thereafter 5,268 Total expected amortization expense $ 21,154
Schedule of the Changes in the Carrying Amount of Goodwill	The changes in the carrying amount of goodwill were as follows (in thousands): December 31, 2023 $ 112,097 Foreign currency translation adjustments (1,780) March 31, 2024 $ 110,317

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2024 March 31, 2023 Class A Class B Class A Class B Numerator Net loss $ (10,869) $ (818) $ (42,819) $ (3,331) Denominator Weighted-average common shares outstanding - basic and diluted 51,070,269 3,845,583 49,815,159 3,875,083 Basic and diluted net loss per share $ (0.21) $ (0.21) $ (0.86) $ (0.86)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2024 March 31, 2023 Shares subject to outstanding common stock options 1,192,676 1,406,771 Shares subject to unvested restricted stock units and performance restricted stock units 2,531,111 2,320,481 Shares issuable pursuant to the ESPP 98,587 99,352 Shares underlying our convertible senior notes 6,132,025 4,304,082

Supplemental Consolidated Bal_3

Supplemental Consolidated Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued Expenses and Other Current Liabilities
Accrued vacation	$ 17,759	$ 15,356
Accrued commissions	7,843	11,969
Accrued bonuses	8,256	6,825
Accrued payroll	7,660	7,206
Estimated health insurance claims	2,463	3,462
Accrued interest	1,197	3,510
ESPP employee contributions	4,319	7,540
Customer deposits	22,307	24,763
Operating lease liabilities	4,489	5,256
Accrued other liabilities	13,144	12,034
Accrued expenses and other current liabilities	$ 89,437	$ 97,921

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	$ 296,066	$ 256,100	$ 195,485
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	542,693	556,627
Marketable securities, unrealized gains	274	1,284
Marketable securities, unrealized losses	(686)	(289)
Marketable securities, aggregate fair value	542,281	557,622
Cash and cash equivalents and available-for-sale securities, amortized cost	684,630	665,453
Cash and cash equivalents and marketable securities, aggregate fair value	684,218	666,448
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	21,119	56,115
Marketable securities, unrealized gains	0	0
Marketable securities, unrealized losses	0	0
Marketable securities, aggregate fair value	21,119	56,115
U.S. treasury debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, unrealized gains	84	531
Marketable securities, unrealized losses	(283)	(80)
Cash and cash equivalents and available-for-sale securities, amortized cost	263,751	224,136
Cash and cash equivalents and marketable securities, aggregate fair value	263,552	224,587
U.S. government agency debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	99,374	110,036
Marketable securities, unrealized gains	45	256
Marketable securities, unrealized losses	(103)	(15)
Marketable securities, aggregate fair value	99,316	110,277
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	178,987	165,341
Marketable securities, unrealized gains	145	497
Marketable securities, unrealized losses	(298)	(187)
Marketable securities, aggregate fair value	178,834	165,651
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	1,000	999
Marketable securities, unrealized gains	0	0
Marketable securities, unrealized losses	(2)	(7)
Marketable securities, aggregate fair value	998	992
Money market funds
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	120,399	108,826
Cash and cash equivalents, aggregate fair value	120,399	108,826
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	141,937	108,826
Cash and cash equivalents, aggregate fair value	$ 141,937	$ 108,826

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Due within one year	$ 359,459
Due in one to two years	182,822
Marketable securities	$ 542,281	$ 557,622

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Continuous Unrealized Loss Position (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Fair Value
Less than 12 months	$ 372,987
12 months or greater	11,064
Unrealized Loss
Less than 12 months	(648)
12 months or greater	(38)
U.S. treasury debt securities
Fair Value
Less than 12 months	191,040
12 months or greater	2,083
Unrealized Loss
Less than 12 months	(275)
12 months or greater	(8)
U.S. government agency debt securities
Fair Value
Less than 12 months	68,527
12 months or greater	0
Unrealized Loss
Less than 12 months	(103)
12 months or greater	0
Corporate debt securities
Fair Value
Less than 12 months	113,420
12 months or greater	7,983
Unrealized Loss
Less than 12 months	(270)
12 months or greater	(28)
Foreign government debt securities
Fair Value
Less than 12 months	0
12 months or greater	998
Unrealized Loss
Less than 12 months	0
12 months or greater	$ (2)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 542,281	$ 557,622
Cash and cash equivalents and marketable securities	684,218	666,448
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	21,119	56,115
U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	263,552	224,587
U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	99,316	110,277
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	178,834	165,651
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	998	992
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	120,399	108,826
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	141,937	108,826
Level 2 | 2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	86,200
Level 2 | 2028 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	651,900
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	542,281	557,622
Total assets measured at fair value	684,218	666,448
Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	21,119	56,115
Recurring | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	263,552	224,587
Recurring | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	99,316	110,277
Recurring | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	178,834	165,651
Recurring | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	998	992
Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	120,399	108,826
Recurring | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	141,937	108,826
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	120,399	108,826
Recurring | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	0	0
Recurring | Level 1 | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	120,399	108,826
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	563,819	557,622
Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	21,119	56,115
Recurring | Level 2 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and marketable securities	263,552	224,587
Recurring | Level 2 | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	99,316	110,277
Recurring | Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	178,834	165,651
Recurring | Level 2 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	998	992
Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 0	$ 0

Convertible Senior Notes - Summ

Convertible Senior Notes - Summary of Convertible Debt (Details) - Convertible debt	1 Months Ended
	Aug. 31, 2023 USD ($) $ / shares	Aug. 31, 2019 USD ($) $ / shares
2026 Notes
Debt Instrument [Line Items]
Original Principal (including overallotment) | $		$ 345,000,000
Initial Conversion Rate		0.0124756
Initial Conversion Price (in dollars per share) | $ / shares		$ 80.16
2028 Notes
Debt Instrument [Line Items]
Original Principal (including overallotment) | $	$ 702,000,000
Initial Conversion Rate	0.007469
Initial Conversion Price (in dollars per share) | $ / shares	$ 133.89

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details)	1 Months Ended		3 Months Ended
	Aug. 31, 2023 USD ($) day $ / shares	Aug. 31, 2019 USD ($)	Mar. 31, 2024 $ / shares	Dec. 31, 2023 $ / shares
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.001		$ 0.001	$ 0.001
Convertible debt | Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold number of trading days (day) | day	20
Threshold number of consecutive trading days (day) | day	30
Threshold percentage of stock price trigger	130%
Redemption price, percentage	100%
Convertible debt | Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold number of trading days (day) | day	5
Threshold number of consecutive trading days (day) | day	10
Threshold percentage of stock trading price	98%
Convertible debt | 2026 Notes
Debt Instrument [Line Items]
Face amount of debt issued		$ 345,000,000
Stated interest percentage		1.125%
Proceeds from the issuance of convertible senior notes		$ 335,900,000
Effective interest percentage			1.50%
Remaining life of debt instrument			2 years 3 months 18 days
Convertible debt | 2026 Notes, over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued		$ 45,000,000
Convertible debt | 2028 Notes
Debt Instrument [Line Items]
Face amount of debt issued	$ 702,000,000
Stated interest percentage	1.25%
Proceeds from the issuance of convertible senior notes	$ 691,100,000
Effective interest percentage			1.60%
Remaining life of debt instrument			4 years 4 months 24 days
Convertible debt | 2028 Notes, over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued	77,000,000
Maximum face amount for over-allotment option	$ 100,000,000

Convertible Senior Notes - Net

Convertible Senior Notes - Net Carrying Amount of Convertible Debt (Details) - Convertible debt - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
2026 Notes
Debt Instrument [Line Items]
Principal	$ 71,242	$ 71,242
Unamortized issuance costs	(643)	(711)
Net carrying amount	70,599	70,531
2028 Notes
Debt Instrument [Line Items]
Principal	702,000	702,000
Unamortized issuance costs	(9,536)	(10,076)
Net carrying amount	$ 692,464	$ 691,924

Convertible Senior Notes - Su_2

Convertible Senior Notes - Summary of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Disclosure [Abstract]
Contractual interest expense	$ 2,394	$ 970
Amortization of issuance costs	608	325
Total interest expense	$ 3,002	$ 1,295

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 23,007	$ 38,042
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	4,641	4,697
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	8,038	6,958
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	8,000	24,682
Subscription and support | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	1,601	1,072
Professional services | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 727	$ 633

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock Options (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Options (in shares):
Outstanding beginning of the period (in shares)	1,211,619
Granted (in shares)	0
Forfeited (in shares)	0
Expired (in shares)	0
Exercised (in shares)	(18,943)
Outstanding end of the period (in shares)	1,192,676	1,211,619
Exercisable (in shares)	1,192,676
Weighted-Average Exercise Price (in dollars per share):
Outstanding beginning of the period (in dollars per share)	$ 14.46
Granted (in dollars per share)	0
Forfeited (in dollars per share)	0
Expired (in dollars per share)	0
Exercised (in dollars per share)	15.93
Outstanding end of the period (in dollars per share)	14.43	$ 14.46
Exercisable (in dollars per share)	$ 14.43
Outstanding, weighted-average remaining contractual term (years)	2 years 1 month 6 days	2 years 3 months 18 days
Exercisable, weighted-average remaining contractual term (years)	2 years 1 month 6 days

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units and Performance Restricted Stock Units (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Shares subject to unvested restricted stock units and performance restricted stock units
Number of Shares (in shares)
Unvested at beginning of period (in shares)	2,198,411
Granted (in shares)	947,282
Forfeited (in shares)	(39,340)
Vested (in shares)	(575,242)
Unvested at end of period (in shares)	2,531,111
Weighted- Average Grant Date Fair Value (in dollars per share)
Unvested at beginning of period (in dollars per share) | $ / shares	$ 97.17
Granted (in dollars per share) | $ / shares	94.78
Forfeited (in dollars per share) | $ / shares	101.42
Vested (in dollars per share) | $ / shares	98.25
Unvested at end of period (in dollars per share) | $ / shares	$ 96.02
Restricted stock units
Weighted- Average Grant Date Fair Value (in dollars per share)
Number of vested shares recipients elected to defer settlement, released during period (in shares)	14,840

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from shares issued in connection with employee stock purchase plan	$ 7,113	$ 5,546
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 1,400
Unrecognized compensation expense, period for recognition (years)	3 months 18 days
Class A Common Stock | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued during period (in shares)	88,047
Shares issued during period, weighted average price per share (in dollars per share)	$ 80.79
Proceeds from shares issued in connection with employee stock purchase plan	$ 7,100

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 175,667	$ 150,189
Subscription and support
Disaggregation of Revenue [Line Items]
Total revenue	154,979	129,664
XBRL professional services
Disaggregation of Revenue [Line Items]
Total revenue	17,593	16,733
Other services
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,095	$ 3,792

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Transaction Price Allocated to the Remaining Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 142.3	$ 118.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	931.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	$ 515
Expected period of recognition	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected period of recognition	24 months

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Intangible Asset Components (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	7 years 2 months 12 days
Gross Carrying Amount	$ 36,184	$ 36,698
Accumulated Amortization	(15,030)	(13,806)
Net Carrying Amount	$ 21,154	22,892
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	4 years 6 months
Gross Carrying Amount	$ 15,765	15,949
Accumulated Amortization	(8,294)	(7,471)
Net Carrying Amount	$ 7,471	8,478
Acquired customer-related
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 15,081	15,427
Accumulated Amortization	(3,084)	(2,769)
Net Carrying Amount	$ 11,997	12,658
Acquired trade names
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	2 years 10 months 24 days
Gross Carrying Amount	$ 2,156	2,172
Accumulated Amortization	(1,750)	(1,721)
Net Carrying Amount	$ 406	451
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 3,182	3,150
Accumulated Amortization	(1,902)	(1,845)
Net Carrying Amount	$ 1,280	$ 1,305

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 1.4	$ 1.5

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Amortization of Intangible Assets by Fiscal Year (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 4,074
2025	4,699
2026	3,380
2027	2,085
2028	1,648
Thereafter	5,268
Net Carrying Amount	$ 21,154	$ 22,892

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Goodwill Activity (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 112,097
Foreign currency translation adjustments	(1,780)
Goodwill, ending balance	$ 110,317

Net Loss Per Share - Earnings P

Net Loss Per Share - Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Denominator
Weighted-average common shares outstanding - basic (in shares)	54,915,852	53,690,242
Weighted-average common shares outstanding - diluted (in shares)	54,915,852	53,690,242
Basic net loss per share (in dollars per share)	$ (0.21)	$ (0.86)
Diluted net loss per share (in dollars per share)	$ (0.21)	$ (0.86)
Class A Common Stock
Numerator
Net loss, basic	$ (10,869)	$ (42,819)
Net loss, diluted	$ (10,869)	$ (42,819)
Denominator
Weighted-average common shares outstanding - basic (in shares)	51,070,269	49,815,159
Weighted-average common shares outstanding - diluted (in shares)	51,070,269	49,815,159
Basic net loss per share (in dollars per share)	$ (0.21)	$ (0.86)
Diluted net loss per share (in dollars per share)	$ (0.21)	$ (0.86)
Class B Common Stock
Numerator
Net loss, basic	$ (818)	$ (3,331)
Net loss, diluted	$ (818)	$ (3,331)
Denominator
Weighted-average common shares outstanding - basic (in shares)	3,845,583	3,875,083
Weighted-average common shares outstanding - diluted (in shares)	3,845,583	3,875,083
Basic net loss per share (in dollars per share)	$ (0.21)	$ (0.86)
Diluted net loss per share (in dollars per share)	$ (0.21)	$ (0.86)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,192,676	1,406,771
Shares subject to unvested restricted stock units and performance restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,531,111	2,320,481
Shares issuable pursuant to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	98,587	99,352
Shares underlying our convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,132,025	4,304,082